Evidence map›Paper›PMID 35011973›Full record

ArticleJournal of clinical medicine2021

Association of Regular Endoscopic Screening with Interval Gastric Cancer Incidence in the National Cancer Screening Program.

Choong-Kyun Noh, Eunyoung Lee, Gil Ho Lee, Sun Gyo Lim, Bumhee Park, Sung Jae Shin, Jae Youn Cheong, Kee Myung Lee

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Choong-Kyun NohDepartment of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0002-3607-8120
Eunyoung LeeDepartment of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0002-9440-9119
Gil Ho LeeDepartment of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Korea.
Sun Gyo LimDepartment of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Korea.
Bumhee ParkDepartment of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.
Sung Jae ShinDepartment of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Korea.
Jae Youn CheongDepartment of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Korea.ORCID 0000-0001-6246-1783
Kee Myung LeeDepartment of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although regular endoscopic screening may help in early detection of gastric cancer, interval cancer remains a problem in the screening program. This study evaluated the association between regular endoscopic screening and interval cancer detection in the Korean National Cancer Screening Program (KNCSP). We defined three groups (regularly, irregularly, and not screened) according to the screening interval, and the trends in the interval cancer rate (ICR) between the groups were tested using the Cochran-Armitage test. The influence of regular endoscopic screening on the risk of interval cancer was evaluated using multivariable logistic regression. Among the 11,642,410 participants who underwent endoscopy, the overall ICR was 0.36 per 1000 negative screenings. The ICR of the not screened group (0.41) was the highest among the three groups and the risk of interval cancer in this group was 1.68 times higher (

Indexed as

endoscopygastric cancerinterval cancernational cancer screening programscreening

Identifiers

PMID35011973
PMCPMC8745904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.